Follow
Daniela Staquicini
Daniela Staquicini
Rutgers Cancer Institute of New Jersey
Verified email at rutgers.edu
Title
Cited by
Cited by
Year
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes
G Sharma, C Hu, DI Staquicini, JL Brigman, M Liu, F Mauvais-Jarvis, ...
Science translational medicine 12 (528), eaau5956, 2020
752020
Role of GP82 in the Selective Binding to Gastric Mucin during Oral Infection with Trypanosoma cruzi
DI Staquicini, RM Martins, S Macedo, GRS Sasso, VD Atayde, MA Juliano, ...
PLoS neglected tropical diseases 4 (3), e613, 2010
682010
Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue
A Salameh, AC Daquinag, DI Staquicini, Z An, KA Hajjar, R Pasqualini, ...
JCI insight 1 (10), 2016
652016
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer
F Ferrara, DI Staquicini, WHP Driessen, S D’Angelo, AS Dobroff, M Barry, ...
Proceedings of the National Academy of Sciences 113 (45), 12786-12791, 2016
532016
Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain
DI Staquicini, FHF Tang, C Markosian, VJ Yao, FI Staquicini, ...
Proceedings of the national academy of sciences 118 (30), e2105739118, 2021
412021
Interaction between tumor cell surface receptor RAGE and proteinase 3 mediates prostate cancer metastasis to bone
MG Kolonin, A Sergeeva, DI Staquicini, TL Smith, CA Tarleton, ...
Cancer research 77 (12), 3144-3150, 2017
402017
Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting
DI Staquicini, R Rangel, L Guzman-Rojas, FI Staquicini, AS Dobroff, ...
Scientific reports 7 (1), 4243, 2017
362017
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes
AS Dobroff, S D’Angelo, BL Eckhardt, F Ferrara, DI Staquicini, ...
Proceedings of the National Academy of Sciences 113 (45), 12780-12785, 2016
362016
TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection
IP Sauter, KG Madrid, JB de Assis, A Sá-Nunes, AC Torrecilhas, ...
JCI insight 4 (10), 2019
352019
Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy
D Canals, S Salamone, BJ Santacreu, E Nemeth, D Aguilar, ...
FASEB journal: official publication of the Federation of American Societies …, 2020
292020
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates
DI Staquicini, S D'Angelo, F Ferrara, K Karjalainen, G Sharma, TL Smith, ...
The pharmacogenomics journal 18 (3), 436-443, 2018
292018
Targeted phage display-based pulmonary vaccination in mice and non-human primates
DI Staquicini, EM Barbu, RL Zemans, BK Dray, FI Staquicini, P Dogra, ...
Med 2 (3), 321-342. e8, 2021
262021
Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer
FI Staquicini, A Hajitou, WHP Driessen, B Proneth, M Cardó-Vila, ...
Elife 10, e65145, 2021
212021
Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications
S D’Angelo, FI Staquicini, F Ferrara, DI Staquicini, G Sharma, CA Tarleton, ...
JCI insight 3 (9), 2018
172018
Induction of proinflammatory cytokines and nitric oxide by Trypanosoma cruzi in renal cells
GM de Oliveira, N Yoshida, EMS Higa, S Shenkman, M Alves, ...
Parasitology research 109, 483-491, 2011
132011
Genetic and structural analysis of SARS-CoV-2 spike protein for universal epitope selection
C Markosian, DI Staquicini, P Dogra, E Dodero-Rojas, JH Lubin, ...
Molecular biology and evolution 39 (5), msac091, 2022
92022
Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.
LL Niborski, M Potenza, RGS Chirivi, L Simonetti, MS Ossowski, V Grippo, ...
EBioMedicine 63, 2021
62021
A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection
P Dogra, C Schiavone, Z Wang, J Ruiz-Ramírez, S Caserta, DI Staquicini, ...
JCI insight 8 (13), 2023
32023
Apropos of Universal Epitope Discovery for COVID-19 Vaccines: A Framework for Targeted Phage Display-Based Delivery and Integration of New Evaluation Tools
C Markosian, DI Staquicini, P Dogra, E Dodero-Rojas, FHF Tang, ...
Biorxiv, 2021
32021
Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands
DI Staquicini, M Cardó-Vila, JA Rotolo, FI Staquicini, FHF Tang, TL Smith, ...
Proceedings of the National Academy of Sciences 120 (34), e2220269120, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20